Fundz

PlaqueTec raises $5 million in an oversubscribed financing round, funded by existing investors, to support its proprietary cardiovascular data lake, BioCarta.

PRIVATEApr 27, 2026

Amount Raised

$5 Million

Round Type

Funding Round

CambridgeBiotechnologyHealth CareMedical

Description

PlaqueTec, a medtech company, announced it raised $5 million in a financing round supported entirely by existing investors. The funding will facilitate the development of BioCarta, a cardiovascular data lake aimed at improving CVD assessments. Chairman Martin Stapleton highlights the confidence of shareholders in their innovative approach to cardiovascular therapeutics. This round secures the company's strategy to enhance patient outcomes significantly.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as PlaqueTec that raised within 45 days of this round, from Fundz verified event records.

  • ThruFlo Endovascular raised an undisclosed amount (Seed) on June 11, 2026.
  • Uncovr raised $7M (Seed) on June 10, 2026.
  • NVENTRIC raised $23M on June 10, 2026.
  • FesariusTherapeutics raised $20M (Series A) on June 10, 2026.
  • GT Medical Technologies raised $100M (Funding Round) on June 10, 2026.
  • NeOnc Technologies raised $15M on June 10, 2026.

Who to call at PlaqueTec, and when

A new round usually means PlaqueTec is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PlaqueTec raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PlaqueTec, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PlaqueTec. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PlaqueTec

Location

Cambridge, England, United Kingdom

About

PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine. CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression. A more detailed understanding of patient endotypes will support drug development by identifying new targets in specific patient groups, reducing clinical trial sizes and costs, and increasing success rates, ultimately improving outcomes for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PlaqueTec raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for PlaqueTec's next move

See what Strategic adds

PlaqueTec raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.